Menthol

Description

Absorbine Jr.® is a medicated patch containing 7.5% menthol, designed to deliver deep penetrating relief for back and muscle pain. The patch is formulated to provide fast-acting relief that lasts up to 8 hours, targeting pain at the source. It is constructed to contour comfortably to the body, ensuring a breathable fit. Each patch measures 9 × 4 inches (22 × 10 cm) and is specifically developed to alleviate deep-seated aches and pains associated with regular or activity-induced back pain. This product is manufactured in China.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, sprains, strains, and bruises. It is specifically formulated to provide deep penetrating relief for back and muscle pain, particularly for individuals experiencing regular or activity-induced back pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage of the product containing Menthol 7.5% is to apply a sufficient amount to the affected area. The application should be performed up to four times daily, as needed.

Prior to application, the affected area should be clean and dry. A thin layer of the product should be gently massaged into the skin until fully absorbed. Care should be taken to avoid contact with eyes and mucous membranes.

Healthcare professionals should monitor patients for any adverse reactions, particularly with prolonged use or in sensitive populations.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product should not be applied to wounds or damaged skin. The use of a heating pad in conjunction with this product is contraindicated. Healthcare professionals should advise patients to consult a physician prior to use if there is any redness present over the affected area.

While using this product, it is imperative to avoid contact with the eyes and mucous membranes. Additionally, patients should be instructed not to bandage the area tightly to prevent complications.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Patients are advised to discontinue use and consult a healthcare provider if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Furthermore, if excessive skin irritation occurs, it is essential to stop use and seek medical advice.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not be applied to wounds or damaged skin. Additionally, it should not be used in conjunction with a heating pad. Patients are advised to consult a doctor prior to use if there is any redness over the affected area.

While using this product, it is crucial to avoid contact with the eyes and mucous membranes. Furthermore, patients should refrain from tightly bandaging the area of application.

Patients are instructed to discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. In cases of excessive skin irritation, it is also recommended to stop use and consult a healthcare professional.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Absorbine Jr Back Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a doctor before use. For adolescents and children aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information regarding the use of Absorbine Jr. Back Patch in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful monitoring for any potential adverse effects or interactions. It is advisable to consider the overall health status and comorbidities of geriatric patients when determining the appropriateness of this treatment.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use, as there may be potential risks to the fetus. Specific studies or data regarding fetal outcomes are not provided in the prescribing information.

While no specific dosage modifications for pregnant individuals are mentioned, it is essential for healthcare providers to offer personalized advice based on individual circumstances. Use during pregnancy should be approached with caution, and medical advice should be sought prior to use to ensure the safety of both the patient and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of Absorbine Jr. Back Patch in lactating mothers. Additionally, the insert does not provide any specific considerations or precautions related to lactation or breastfeeding. Therefore, healthcare professionals may consider the use of this product in nursing mothers without specific concerns related to breast milk excretion or effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms improve and then recur within a few days. Additionally, they should be cautioned to stop using the medication if they experience excessive skin irritation.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Additionally, it should be kept out of reach of children to prevent accidental ingestion. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients aged 12 years and older are advised to apply the product to the affected area no more than 3 to 4 times daily. Clinicians should counsel patients to consult a doctor prior to use if there is redness over the affected area. While using the product, patients must avoid contact with eyes and mucous membranes, and should not bandage the area tightly. They should discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, if symptoms clear up and then recur within a few days, or if excessive skin irritation occurs.

Drug Information (PDF)

This file contains official product information for Absorbine Jr Back Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)